Treatment Options for Polycystic Ovary Syndrome

Le résumé fourni par la source

This chapter, in accordance with current evidence-based treatments, for Polycystic ovary syndrome (PCOS), emphasizes a lifespan, multi-phenotype patients’ management model. This chapter systematically introduces therapeutic options-including lifestyle intervention, pharmacological or surgical interventions—across reproductive, metabolic, and psychological dimensions. Lifestyle intervention is highlighted as the cornerstone throughout the entire treatment process, with an analysis of the strengths and limitations of existing dietary or exercise regimens, tailored to individual patient preferences. Non-pharmacological and pharmacological approaches, including anti-obesity pharmacological agents (e.g., GLP-1RA and orlistat), and inositol will be introduced for fertility and non-infertility feature management. Also, we include pharmacological treatment attention for women in specific lifecycle (e.g., adolescence and pregnancy). It underscores a paradigm shift toward patient-centered, evidence-based practices, integrating multidisciplinary strategies to address the heterogeneous demands of individuals with PCOS.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.